tradingkey.logo

Quanterix Corp

QTRX

5.430USD

-0.150-2.69%
終値 09/19, 16:00ET15分遅れの株価
211.08M時価総額
損失額直近12ヶ月PER

Quanterix Corp

5.430

-0.150-2.69%
詳細情報 Quanterix Corp 企業名
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.
企業情報
企業コードQTRX
会社名Quanterix Corp
上場日Dec 07, 2017
最高経営責任者「CEO」Dr. Masoud Toloue, Ph.D.
従業員数471
証券種類Ordinary Share
決算期末Dec 07
本社所在地900 Middlesex Turnpike
都市BILLERICA
証券取引所NASDAQ Global Market Consolidated
United States of America
郵便番号01821
電話番号16173019400
ウェブサイトhttps://www.quanterix.com/
企業コードQTRX
上場日Dec 07, 2017
最高経営責任者「CEO」Dr. Masoud Toloue, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
288.86K
-0.43%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
133.06K
+5.49%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
15.30K
+34.46%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
4.19K
--
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Independent Director
Independent Director
3.96K
-79.63%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
2.94K
--
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Paul M. Meister
Mr. Paul M. Meister
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
288.86K
-0.43%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
133.06K
+5.49%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
15.30K
+34.46%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
4.19K
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
地域別USD
会社名
収益
比率
North America
19.38M
64.01%
EMEA
6.63M
21.92%
Asia Pacific
4.26M
14.07%
事業別
地域別
事業別USD
会社名
収益
比率
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Portolan Capital Management, L.L.C.
7.82%
Columbia Threadneedle Investments (UK)
6.73%
BlackRock Institutional Trust Company, N.A.
5.70%
The Vanguard Group, Inc.
5.44%
Kent Lake PR LLC
4.50%
他の
69.81%
株主統計
株主統計
比率
Portolan Capital Management, L.L.C.
7.82%
Columbia Threadneedle Investments (UK)
6.73%
BlackRock Institutional Trust Company, N.A.
5.70%
The Vanguard Group, Inc.
5.44%
Kent Lake PR LLC
4.50%
他の
69.81%
種類
株主統計
比率
Investment Advisor/Hedge Fund
34.26%
Investment Advisor
20.99%
Hedge Fund
13.18%
Individual Investor
6.47%
Research Firm
3.94%
Pension Fund
0.67%
Bank and Trust
0.27%
Family Office
0.13%
Venture Capital
0.12%
他の
19.97%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
391
36.46M
81.18%
-12.95M
2025Q1
401
40.45M
104.19%
-6.42M
2024Q4
388
38.02M
98.63%
-6.28M
2024Q3
386
36.47M
95.03%
-5.94M
2024Q2
394
35.66M
93.20%
-9.57M
2024Q1
395
35.56M
93.43%
-9.17M
2023Q4
388
34.77M
91.99%
-10.35M
2023Q3
382
36.53M
97.35%
-9.84M
2023Q2
388
36.74M
98.24%
-9.95M
2023Q1
389
37.25M
100.03%
-8.36M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Portolan Capital Management, L.L.C.
2.96M
7.63%
+375.57K
+14.51%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
3.00M
7.72%
+237.57K
+8.60%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.68M
6.91%
-89.03K
-3.21%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
6.5%
+316.41K
+14.32%
Mar 31, 2025
Kent Lake PR LLC
2.92M
7.53%
+279.82K
+10.58%
Mar 31, 2025
Walt (David R)
1.86M
4.79%
+370.00K
+24.84%
Jun 13, 2025
Invenomic Capital Management LP
902.04K
2.32%
+546.67K
+153.83%
Mar 31, 2025
William Blair Investment Management, LLC
1.11M
2.85%
+43.96K
+4.14%
Mar 31, 2025
Columbia Threadneedle Investments (US)
716.23K
1.84%
+271.74K
+61.14%
Mar 31, 2025
Easterly Investment Partners LLC
1.33M
3.41%
+370.63K
+38.81%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI